[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: NCRP 136 and 137 now available
I have reviewed and commented on NCRP-136. One aspect of this report
that I did not comment on has me puzzled and perhaps someone else who has
reviewed the report can enlighten me.
Most of the material covered in Chapters 3 to 9 seemed to be irrelavent
to the overall subject and I really could not understand how the information
discussed in the body of the report tracked to its conclusions. For example,
how does the discussion of DNA repair, oncogenic transformation, etc. affect
the question of whether LNT is a valid concept and/or reasonable basis for
low-dose radiation exposure standards????
----- Original Message -----
From: Sandy Perle <sandyfl@EARTHLINK.NET>
To: <radsafe@list.vanderbilt.edu>; <powernet@hps1.org>
Sent: Friday, October 19, 2001 10:30 AM
Subject: NCRP 136 and 137 now available
NCRP Report No. 136
Evaluation of the
Linear-Nonthreshold Dose-Response
Model for Ionizing Radiation
NCRP Report No. 136 on Evaluation of the Linear-Nonthreshold Dose-
Response Model for Ionizing Radiation is 263 pages long with 12 sections
and references. It begins with 1. Executive Summary followed by 2.
Introduction, 3. a Biophysical section, and 4. Deoxyribonucleic Acid Repair
and Processing after Low Doses and Low-Dose Rates of Ionizing Radiation.
These are followed by 5. a section on Mutagenesis, 6. a section on
Chromosome Aberrations Induced by Low Doses and Low-Dose Rates of
Ionizing Radiation, 7. Oncogenic Transformation In Vitro and Genomic
Instability, 8. Carcinogenic Effects in Laboratory Animals, 9. Carcinogenic
Effects in Human Populations"Epidemiological Data, 10. Adaptive
Responses, 11. Research Needs, and concluding with 12. Discussion and
Conclusions.
=============
Fluence-Based and Microdosimetric Event-Based Methods for Radiation
Protection in Space (2001)
NCRP site has the incorrect abstract for this Publication. I have informed
them of this fact.
------------------------------------------------------------------------
Sandy Perle Tel:(714) 545-0100 / (800) 548-5100
Director, Technical Extension 2306
ICN Worldwide Dosimetry Service Fax:(714) 668-3149
ICN Pharmaceuticals, Inc. E-Mail: sandyfl@earthlink.net
ICN Plaza, 3300 Hyland Avenue E-Mail: sperle@icnpharm.com
Costa Mesa, CA 92626
Personal Website: http://sandyfl.nukeworker.net
ICN Worldwide Dosimetry Website: http://www.dosimetry.com
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.